In the present study, decreased protein expression levels of Syt-1 and Syn-1 were present in the hippocampus of NAFLD rats, and treatment with QUE increased the levels of these two synaptic-related proteins. The gene discussed is SYN1; the disease is metabolic dysfunction-associated steatotic liver disease.